Sleep Duration and the Risk of Prostate Cancer: the Ohsaki Cohort Study

Overview

Journal Br J Cancer

Specialty Oncology

Date 2008 Jun 11

PMID 18542076

Citations 50

Authors

M Kakizaki

K Inoue

S Kuriyama

T Sone

K Matsuda-Ohmori

N Nakaya

S Fukudo

I Tsuji

Affiliations

Soon will be listed here.

Abstract

In a prospective study of prostate cancer incidence (127 cases), among 22 320 Japanese men, sleep duration was associated with lower risk; the multivariate hazard ratio of men who slept >or=9 h per day compared with those who slept less was 0.48 (95% confidence interval: 0.29-0.79, P for trend=0.02).

Citing Articles

Association of sleep duration and all-cause and cancer-specific mortality: results of 2004 national health interview survey (NHIS).

Biswas P, Adebile T, Sejoro S, Liu M, Zhang X, Tu W Sleep Biol Rhythms. 2025; 23(1):55-65.

PMID: 39801935 PMC: 11717743. DOI: 10.1007/s41105-024-00551-y.

A review for the impacts of circadian disturbance on urological cancers.

Li T, Jiang Y, Bai Y, Jiang K, Du G, Chen P Sleep Biol Rhythms. 2024; 22(2):163-180.

PMID: 38524168 PMC: 10959858. DOI: 10.1007/s41105-023-00500-1.

The role of circadian clock in regulating cell functions: implications for diseases.

Lin Y, He L, Cai Y, Wang X, Wang S, Li F MedComm (2020). 2024; 5(3):e504.

PMID: 38469551 PMC: 10925886. DOI: 10.1002/mco2.504.

Sleep disorders and cancer incidence: examining duration and severity of diagnosis among veterans.

Burch J, Delage A, Zhang H, McLain A, Ray M, Miller A Front Oncol. 2024; 14:1336487.

PMID: 38469244 PMC: 10927008. DOI: 10.3389/fonc.2024.1336487.

Insomnia disorder and cancer mortality in South Korea: a secondary analysis of musculoskeletal disease cohort.

Oh T, Park H, Song I Sleep Breath. 2024; 28(3):1311-1318.

PMID: 38418767 DOI: 10.1007/s11325-024-03009-0.

References

Conlon M, Lightfoot N, Kreiger N . Rotating shift work and risk of prostate cancer. Epidemiology. 2006; 18(1):182-3. DOI: 10.1097/01.ede.0000249519.33978.31. View

Schwartzbaum J, Ahlbom A, Feychting M . Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health. 2007; 33(5):336-43. DOI: 10.5271/sjweh.1150. View

Megdal S, Kroenke C, Laden F, Pukkala E, Schernhammer E . Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer. 2005; 41(13):2023-32. DOI: 10.1016/j.ejca.2005.05.010. View

Brzezinski A . Melatonin in humans. N Engl J Med. 1997; 336(3):186-95. DOI: 10.1056/NEJM199701163360306. View

Shiu S . Towards rational and evidence-based use of melatonin in prostate cancer prevention and treatment. J Pineal Res. 2007; 43(1):1-9. DOI: 10.1111/j.1600-079X.2007.00451.x. View

Schernhammer E, Schulmeister K . Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels?. Br J Cancer. 2004; 90(5):941-3. PMC: 2409637. DOI: 10.1038/sj.bjc.6601626. View

Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y . Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. 2006; 296(10):1255-65. DOI: 10.1001/jama.296.10.1255. View

Verkasalo P, Lillberg K, Stevens R, Hublin C, Partinen M, Koskenvuo M . Sleep duration and breast cancer: a prospective cohort study. Cancer Res. 2005; 65(20):9595-600. DOI: 10.1158/0008-5472.CAN-05-2138. View

Wehr T . The durations of human melatonin secretion and sleep respond to changes in daylength (photoperiod). J Clin Endocrinol Metab. 1991; 73(6):1276-80. DOI: 10.1210/jcem-73-6-1276. View

10.

Martin J, Klein D . Melatonin inhibition of the neonatal pituitary response to luteinizing hormone-releasing factor. Science. 1976; 191(4224):301-2. DOI: 10.1126/science.1108199. View

11.

Youngstedt S, Kripke D . Long sleep and mortality: rationale for sleep restriction. Sleep Med Rev. 2004; 8(3):159-74. DOI: 10.1016/j.smrv.2003.10.002. View

12.

Feychting M, Osterlund B, Ahlbom A . Reduced cancer incidence among the blind. Epidemiology. 1998; 9(5):490-4. View

13.

Kubo T, Ozasa K, Mikami K, Wakai K, Fujino Y, Watanabe Y . Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan collaborative cohort study. Am J Epidemiol. 2006; 164(6):549-55. DOI: 10.1093/aje/kwj232. View

14.

Kliukiene J, Tynes T, Andersen A . Risk of breast cancer among Norwegian women with visual impairment. Br J Cancer. 2001; 84(3):397-9. PMC: 2363754. DOI: 10.1054/bjoc.2000.1617. View

15.

Tsuji I, Nishino Y, Ohkubo T, Kuwahara A, Ogawa K, Watanabe Y . A prospective cohort study on National Health Insurance beneficiaries in Ohsaki, Miyagi Prefecture, Japan: study design, profiles of the subjects and medical cost during the first year. J Epidemiol. 1999; 8(5):258-63. DOI: 10.2188/jea.8.258. View

16.

McElroy J, Newcomb P, Titus-Ernstoff L, Trentham-Dietz A, Hampton J, Egan K . Duration of sleep and breast cancer risk in a large population-based case-control study. J Sleep Res. 2006; 15(3):241-9. DOI: 10.1111/j.1365-2869.2006.00523.x. View

17.

Verkasalo P, Pukkala E, Stevens R, Ojamo M, Rudanko S . Inverse association between breast cancer incidence and degree of visual impairment in Finland. Br J Cancer. 1999; 80(9):1459-60. PMC: 2363081. DOI: 10.1038/sj.bjc.6690544. View

18.

Pinheiro S, Schernhammer E, Tworoger S, Michels K . A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res. 2006; 66(10):5521-5. DOI: 10.1158/0008-5472.CAN-05-4652. View

19.

Aleandri V, Spina V, Morini A . The pineal gland and reproduction. Hum Reprod Update. 1996; 2(3):225-35. DOI: 10.1093/humupd/2.3.225. View